Search Results 2501-2510 of 16456 for pneumococcal vaccination

  1. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    Has received an investigational drug (including investigational vaccines) or used an investigational medical device within 3 months or 5 half-lives, whichever ...

  2. Mayo Clinic Q and A: Getting ready to get pregnant

    At the appointment, you also can review your immunization record and make plans to get missing vaccinations before you get pregnant. Your sexual health can ...

  3. Joel Streed | Mayo Clinic News Network - Page 55 of 168

    Vaccinations often are thought of as a childhood recommendation, but there are important vaccinations for adults, too. Between 50,000 and 100,000 Americans ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... injection, Singing voice evaluation, Thyroplasty, Zenker's diverticulectomy, Laryngeal Botox injection, Airway stenting, Cricopharyngeal myotomy, Laser ...

  5. Publications - Yemi Sokumbi, M.D. - Mayo Clinic

    Soft pink plaques at site of breast cancer vaccination: challenge. 2024; 46 ... Rubella Vaccine Persistence Within Cutaneous Granulomas in Common ...

  6. Vuyisile T. Nkomo, M.D., M.P.H.

    Nkomo, M.D., M.P.H., is a cardiologist with an interest in echocardiography and heart valve disease. His clinical focus includes: Valve disease diagnosis and ...

  7. A Study to Compare the Rate of Major Cardiovascular Implantable Electronic Device Infections with the Absorbable Antibacterial Envelope and without - Mayo Clinic

    ... pneumonia, urinary tract, cellulitis, or bacteremia); Systemic lupus erythematous, because minocycline has been reported to aggravate this condition; Is ...

  8. Something to Think About: Our first flight

    (VIDEO) The reality of RSV, who should get vaccinated. News Releases. Mayo Clinic Alumni Association announces 2024 Distinguished Alumni Award recipients. Mayo ...

  9. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    - Received a live, attenuated vaccine within 4 weeks before the first dose of study treatment, or in whom it is anticipated that such a vaccine will be ...

  10. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subjects must have documentation of positive varicella zoster virus (VZV) immunoglobulin G (IgG) antibody status or complete VZV vaccination at least 30 days ...